Clinical Trials Directory

Trials / Completed

CompletedNCT00817024

Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)

Clinical Study of Herbal Formula in Post PCI Patients.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

We conduct this clinical trial to determine the effects of Xuefu Zhuyu capsule (based on TCM "Zheng Hou" theory) in helping recovery from coronary heart disease(CHD)after PCI and find out whether this kind of effecacy is much better within patients administered with TCM syndrome-based individualized medication.

Detailed description

The effectiveness of a Chinese herbal formulae is not completely based on the disease or some biomedical indexes, but much more on the TCM syndrome(Chinese name:Zheng Hou)which is generalized from patients' TCM signs and symptoms. Thus, conventional medical curative effecacy evaluation system seems not to so fit for TCM clinical studies. Although many clinical studies from Chinese literature have reported the beneficial effects of various of TCM herbal agents in improving symptoms and signs as well as antagonism of specific pathological changes in CHD patients, most of these trials are lack of well-designed methodologies and the reliability of results still remains unclear. Therefore, we designed this clinical trial, with a randomized, placebo controlled way, to evaluate the curative effects of Xuefu Zhuyu capsule(a Chinese herbal medicine)in patients with Post-PCI CHD patients and find out whether this effects will be better displayed within subjects administered with syndrome-based individualized medication.

Conditions

Interventions

TypeNameDescription
DRUGXuefu Zhuyu Capsules Plus Placebo of Sheng Mai Capsules,3# XFZY capsules plus 3# placebo of SM capsules, po, Tid, for 4 weeks
DRUGSheng Mai Capsules Plus Placebo of Xuefu Zhuyu Capsules3# SM capsules plus 3# placebo of XFZY capsules, po, Tid, for 4 weeks
DRUGPlacebo of Xuefu Zhuyu Capsules Plus Placebo of Sheng Mai Capsules3# Placebo of XFZY capsules plus 3# placebo of SM capsules, po, Tid, for 4 weeks

Timeline

Start date
2008-03-01
Primary completion
2009-03-01
Completion
2009-03-01
First posted
2009-01-06
Last updated
2012-06-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00817024. Inclusion in this directory is not an endorsement.

Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients Wit (NCT00817024) · Clinical Trials Directory